ORBICULAR PHARM TECH vs Philips North America: FDA Enforcement Comparison

Philips North America has been the subject of 355 FDA enforcement/approval records tracked by Argus HQ, compared to 1 for ORBICULAR PHARM TECH.

ORBICULAR PHARM TECH: 0 warning letters, 0 recalls, 1 approval record, 0 Form 483s.

Philips North America: 0 warning letters, 355 recalls, 0 approval records, 0 Form 483s.

Side by side

ORBICULAR PHARM TECH — Warning letters0

Philips North America — Warning letters0

ORBICULAR PHARM TECH — Recalls0

Philips North America — Recalls355

ORBICULAR PHARM TECH — Approval records1

Philips North America — Approval records0

ORBICULAR PHARM TECH — Form 483s0

Philips North America — Form 483s0

Timeline

ORBICULAR PHARM TECH

Most recent FDA action: August 27, 2026

Full history →

Philips North America

Most recent FDA action: July 1, 2026

Full history →

Cite this comparison

Pre-formatted for a story, footnote, or reference list:

"ORBICULAR PHARM TECH vs Philips North America: FDA Enforcement Comparison." Argus HQ, accessed September 5, 2026. https://argushq.ai/compare/orbicular-pharm-tech-vs-philips-north-america

Source: FDA.gov (aggregated across Warning Letters, Recalls, Approvals, Form 483s) ↗